Ask PAM anything about private markets: valuations, sector comparisons, and how tender offers work.Get the iOS appAsk PAM anything about private markets.Get the iOS app

MapLight IPO

Develops targeted treatments for brain disorders using advanced technology to identify and modulate neural circuits.

NASDAQ:MPLT

Buy

Buy Private Stock

Sign up to invest in private companies like MapLight before their IPO.

Sell

Sell Private Stock

Sign up to sell private companies like MapLight before their IPO.

Overview

MapLight completed their IPO on October 27, 2025. Now that MapLight is a public company, Nasdaq Private Market does not actively track its performance. The data below is for reference before the company’s IPO.

MapLight is a biopharmaceutical company dedicated to developing targeted treatments for brain disorders. By leveraging proprietary technologies such as optogenetics and STARmap, they aim to identify and modulate specific neural circuits implicated in conditions like schizophrenia, Alzheimer’s disease psychosis, and autism spectrum disorder. This approach seeks to improve patient outcomes by addressing the underlying neural mechanisms of these disorders.

Sector

Healthcare & Life Sciences

Founded

2019

Headquarters

Redwood City, CA

MapLight Funding

MapLight Funding History Pre-IPO

Gain insights into MapLight funding history prior to their IPO, including the funding round, time period, and amount raised.

Financing Round Date Amount Price per share Valuation
Round Date Amount PPS Valuation
Series D Jul 18, 2025 188M
XXXXX
XXXXX
Series C Nov 02, 2023 55M
XXXXX
XXXXX
Series C Jul 05, 2023 50M
XXXXX
XXXXX
Series B-1 Oct 25, 2022 12M
XXXXX
XXXXX
Series B Oct 25, 2022 21M
XXXXX
XXXXX
Series B Feb 23, 2021 32M
XXXXX
XXXXX
Series A-1 Aug 23, 2019 16M
XXXXX
XXXXX
Series A Feb 22, 2019 5M
XXXXX
XXXXX

Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market

Buy

Buy Private Stock

Sign up to invest in private companies like MapLight before their IPO.

Sell

Sell Private Stock

Sign up to sell private companies like MapLight before their IPO.

MapLight Management Team

MapLight people and management – Prior to IPO

  • Founder, CEO, Board Member
    Christopher A Kroeger
  • CFO
    Vishwas Setia
  • Board Member
    George Pavlov
  • Board Member
    Jim Trenkle
  • Board Member
    Peter Tuxen Bisgaard
  • Board Member
    Robert C. Malenka
  • Board Member
    Timothy Garnett
  • Chief Administrative Officer, Chief Accounting Officer
    Jonathan Gillis
  • Chief Discovery Officer
    Anatol Kreitzer
  • Chief Medical Officer
    Erin Pennock Foff
  • Chief Scientific Officer
    James Lillie

Investors

Major MapLight investors

  • 5AM Ventures

  • Avego Bioscience Capital, L.P.

  • Blue Owl Capital

  • Forbion Capital Partners

  • Goldman Sachs

  • Goldman Sachs Urban Investment Group

  • Novo Holdings

  • Sanofi Ventures

MapLight Valuations & Financials

Looking for private company valuations and share price data?

Nasdaq Private Market Data & Intelligence is the private company valuation database covering 4,000+ venture-backed companies with daily pricing, financing history, and secondary market activity. View real-time NPM data on pre-IPO companies including valuations, private company comparable transactions, and historical share price information — the private company due diligence data sources institutional investors rely on.

Similar Companies

Explore companies

like MapLight

  • BioCoach

    Healthcare & Life Sciences

    Generates personalized meal plans and grocery lists tuned to your health profile and budget.

  • Nanite

    Healthcare & Life Sciences

    Improves delivery of therapeutic molecules into cells using computational modeling and machine learning.

  • MEMS Drive

    Healthcare & Life Sciences

    Creates MEMS‑based precision motion control solutions for AR/VR, robotics, and optical systems.

  • Evergreen Life

    Healthcare & Life Sciences

    Digital health platform providing personal health record access, medical appointment booking, prescription management and wellness tracking.

  • AIxMed

    Healthcare & Life Sciences

    Provides a computational cytology platform which utilizes deep learning computer vision to automate the detection of abnormal cells in digital pathology samples.

  • Fay

    Healthcare & Life Sciences

    Connects individuals with credentialed registered dietitians through an insurance-integrated platform to deliver accessible medical nutrition therapy.

  • Hemanext

    Healthcare & Life Sciences

    Specializes in innovative blood processing and storage solutions to enhance the quality and effectiveness of red blood cell transfusions.

  • Evident Vascular

    Healthcare & Life Sciences

    Develops an AI-powered intravascular ultrasound platform for clearer imaging and improved diagnosis of peripheral vascular diseases.

  • MyWoundDoctor

    Healthcare & Life Sciences

    Facilitates remote monitoring and expert-guided treatment plans for improved healing outcomes.

FAQ

Questions?

We have answers

Buy MapLight Stock

MapLight became publicly traded following its IPO on October 27, 2025, its shares now trade on public stock exchanges under the ticker symbol NASDAQ: MPLT. Before the IPO, MapLight stock was privately held and available only through private market transactions.

If you’re an accredited investor looking to purchase pre-IPO shares in a private company, Nasdaq Private Market can help you get started. Learn more about investing in the private market or sign up for free to explore available opportunities. Learn more about how private company shares trade prior to an IPO on our investors page.

Sell MapLight Stock

Following its IPO on October 27, 2025, MapLight shares trade on public stock exchanges, allowing shareholders to sell stock through a traditional brokerage.

If you currently hold shares in a private company, Nasdaq Private Market may be able to help you explore your sell private company stock. Our platform provides a secure and compliant way to sell your shares on terms that work for both you and the company. To understand how employees sell shares before a company goes public, visit the Employee Shareholders page.

 

MapLight Stock Price

Following the IPO, MapLight stock prices can now be viewed publicly on major exchanges. Investors and interested parties can find the current stock price by searching MapLight’s ticker symbol on financial platforms such as Nasdaq.com or through their preferred brokerage platform.

MapLight Stock Ticker Symbol

Following its IPO on October 27, 2025, MapLight stock now trades on public markets under the ticker symbol NASDAQ: MPLT. You can view real-time stock information through widely used financial data platforms.

Criteria to Sell MapLight Stock

Following the MapLight IPO, public shares can be sold through any brokerage.

Nasdaq Private Market works with employees, ex-employees, and other private company shareholders of pre-IPO companies to sell their shares. The Nasdaq Private Market platform provides a secure and compliant way to sell your shares on terms that work for both you and the company. To learn more about how to sell private company stock, visit the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

 

Criteria to Buy or Invest in MapLight Stock

Following MapLight’s initial public offering on October 27, 2025, its shares are now listed on a public exchange and available for purchase through a brokerage account. Investors interested in buying MapLight stock can do so through their preferred broker, just as they would with any other publicly traded security.

Nasdaq Private Market continues to work with investors seeking exposure to private company opportunities prior to IPO. Through structured transactions and curated offerings, investors can participate in private market activity before companies enter the public markets.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

MapLight Stock Settlement

Since MapLight is now publicly traded, public-market share transfers and settlement occur automatically through a brokerage or exchange.

Nasdaq Private Market supports transfer and settlement for privately held company equity. In order to buy or sell private company stock, share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patented Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

MapLight IPO

MapLight completed its IPO on October 27, 2025, and is now publicly available through major financial sources.